Multiple sclerosis (MS) is the result of the immune ... The MS nodules were activated by lymphocytes (a type of immune cell), which were not found in the stroke tissue. When the team took a ...

Fingolimod is a sphingosine 1-phosphate receptor modulator that binds to sphingosine 1-phosphate receptors on lymphocytes ... 1a in relapsing–remitting multiple sclerosis.

Multiple sclerosis (MS) is an autoimmune disease caused by activated autoimmune T lymphocytes in patients resulting in inflammatory demyelination in the central nervous system. A specific therapy ...

Multiple sclerosis (MS) is an inflammatory autoimmune ... natalizumab (TYSABRI®), mediates lymphocyte and monocyte cell adhesion and transendothelial migration via the α4β1 integrin pathway.

Kesimpta is a brand-name subcutaneous injection prescribed for certain forms of multiple sclerosis (MS ... a specific protein present on your lymphocytes (a type of immune cell) known as CD20.

targeting potassium channels for the treatment of chronic diseases (multiple sclerosis, rheumatoid arthritis, and type 1 myotonic dystrophy) and using antioxidant nanomaterials for the treatment of T ...

Multiple sclerosis is a chronic ... that achieves cerebrospinal fluid concentrations predicted to modulate B lymphocytes and disease-associated microglia. Tolebrutinib is being evaluated in ...

FTY720 is an oral S1P-receptor modulator that displays unique immunomodulatory properties: this agent produces a dose-dependent, reversible decrease in blood lymphocyte count resulting both from ...